Enzo targets DNA probes at cytogenetics market
This article was originally published in Clinica
Executive Summary
Enzo Biochem plans to enter the cytogenetics market by producing single copy DNA probes that can identify the "minutest" genetic variations in a number of diseases, paving the way to more effective treatment for genetic conditions and some cancers.